Forms |
|
|---|---|
| Applying for Authorization | |
| Voluntary Licence | |
| Indentity and Status of Product | |
| Monetary Value | |
| Applying for Renewal | |
The pharmaceutical company must complete and submit to the Commissioner of Patents a "Solemn or Statutory Declaration Under Paragraph 21.04(3)(c)
of the Patent Act" (
70 kB;
43 kB). The form sets out the information that must appear in the declaration, including that the company
An attempt to negotiate a voluntary licence is required to comply with Article 31(b) of the World Trade Organization
Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).